A previous study demonstrated that SMAD4 inhibited tumor metastasis in patients with colon cancer through multiple processes including the inhibition of apoptosis, epithelial–mesenchymal transition (EMT), and the PI3K/AKT signaling pathway56. Here, AKT1 is linked to malignant colon neoplasm.